An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer

Lung cancer ranks as a leading cause of death. Although targeted therapies usually trigger profound initial patient responses, these effects are transient due to drug resistance and severe side effects. Xihuang Pill (XHW) is a popular Chinese medicine formula that might benefit cancer patients when...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunyu, Wang, Zhihong, Chen, Wei, Cao, Bo, Zhang, Mingyu, Gu, Qiong, Qi, Shuya, Fei, Xiaofei, Shi, Yafei, Li, Xingjie, Li, RuiSheng, Wang, Jiabo, Li, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381607/
https://www.ncbi.nlm.nih.gov/pubmed/34434895
http://dx.doi.org/10.3389/fonc.2021.697247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381607/
https://www.ncbi.nlm.nih.gov/pubmed/34434895
http://dx.doi.org/10.3389/fonc.2021.697247

Ejemplares similares